X4 Pharmaceuticals Ownership | Who Owns X4 Pharmaceuticals?
X4 Pharmaceuticals Ownership Summary
X4 Pharmaceuticals is owned by 50.77% institutional investors, 1.15% insiders, and 48.08% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.46% of XFOR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in X4 Pharmaceuticals shares.
XFOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | X4 Pharmaceuticals | 50.77% | 1.15% | 48.08% |
| Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 16.92M | 8.46% | $9.81M |
| Nea management company | 14.99M | 7.49% | $8.69M |
| Blackrock | 10.68M | 5.34% | $6.19M |
| Vanguard group | 8.29M | 4.15% | $4.81M |
| Orbimed advisors | 7.13M | 3.57% | $4.14M |
| Kingdon capital management | 4.62M | 2.31% | $2.68M |
| Adage capital partners gp | 4.28M | 2.14% | $2.48M |
| Perceptive advisors | 3.55M | 1.77% | $2.06M |
| Geode capital management | 3.52M | 1.76% | $2.04M |
| Axa | 3.08M | 1.54% | $1.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 16.92M | 1.08% | $9.81M |
| Nea management company | 14.99M | 0.65% | $8.69M |
| Sio capital management | 2.50M | 0.39% | $1.45M |
| Kingdon capital management | 4.62M | 0.29% | $2.68M |
| New leaf venture partners | 335.00K | 0.24% | $194.30K |
| Diametric capital, lp | 448.59K | 0.14% | $260.18K |
| Orbimed advisors | 7.13M | 0.08% | $4.14M |
| Parkman healthcare partners | 806.62K | 0.06% | $467.84K |
| K2 principal fund | 489.16K | 0.05% | $283.71K |
| Perceptive advisors | 3.55M | 0.05% | $2.06M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 10.68M | 0.00% | 1.94M |
| Kingdon capital management | 4.62M | 0.29% | 1.15M |
| Geode capital management | 3.52M | 0.00% | 570.11K |
| K2 principal fund | 489.16K | 0.05% | 489.16K |
| Vanguard group | 8.29M | 0.00% | 462.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | - | - | -4.05M |
| Avidity partners management lp | - | - | -2.41M |
| Morgan stanley | 229.34K | - | -1.18M |
| Sio capital management | 2.50M | 0.39% | -1.09M |
| Goldman sachs group | 171.19K | - | -887.74K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| K2 principal fund | 489.16K | 0.05% | 489.16K | $283.71K |
| Diametric capital, lp | 448.59K | 0.14% | 448.59K | $260.18K |
| Ubs oconnor | 200.00K | 0.00% | 200.00K | $5.00K |
| Prelude capital management | 163.37K | 0.01% | 163.37K | $94.75K |
| Corebridge financial | 90.40K | 0.00% | 90.40K | $52.43K |
Sold Out
| Holder | Change |
|---|---|
| Headlands | -16.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Cubist systematic strategies | -469.00 |
| Jump financial | -10.36K |
| Wolverine trading | -12.60K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 105 | 1.94% | 101,538,962 | -1.42% | 50 | 1.51% | 56 | 43.59% | 18 | -28.00% |
| Mar 31, 2024 | 103 | 7.29% | 103,000,336 | 6.45% | 57 | 2.40% | 39 | -13.33% | 25 | 31.58% |
| Dec 31, 2023 | 96 | - | 96,763,239 | -13.91% | 49 | 1.11% | 45 | 28.57% | 19 | -29.63% |
| Sep 30, 2023 | 96 | -5.88% | 112,397,217 | -2.78% | 66 | 1.06% | 35 | -52.70% | 27 | 170.00% |
| Jun 30, 2023 | 102 | 67.21% | 115,607,337 | 88.16% | 79 | 4.47% | 74 | 164.29% | 10 | -9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.03M | 2.99% | - |
| iShares Russell 2000 ETF | 4.20M | 2.49% | -9.44K |
| UTM IM GBP AXA Framlington Biotech | 2.95M | 1.75% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.94M | 1.15% | - |
| MEDICAL BioHealth EUR Acc | 1.78M | 1.06% | - |
| Fidelity Small Cap Index | 1.74M | 1.03% | -5.88K |
| iShares Russell 2000 Growth ETF | 1.64M | 0.97% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.00M | 0.60% | - |
| Vanguard Russell 2000 ETF | 770.59K | 0.46% | 93.59K |
| Fidelity Extended Market Index | 747.61K | 0.44% | -53.17K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 15, 2024 | Ragan Paula | President and CEO | Sell | $17.93K |
| Oct 07, 2024 | Mostafa Adam S. | Chief Financial Officer | Sell | $126.90K |
| Oct 07, 2024 | Baldry Mark | Chief Commercial Officer | Sell | $6.51K |
| Oct 07, 2024 | Ragan Paula | President and CEO | Sell | $131.52K |
| Oct 07, 2024 | DiBiase Mary | Chief Operating Officer | Sell | $38.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 6 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 8 |
| 2023 Q4 | - | 6 |
XFOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools